| 1 | Manufacturer Profile A | Calcium salt of 5-methyltetrahydrofolate; powder ingredient for dietary supplements and fortified foods | Not publicly disclosed Capacity should be confirmed by site, product grade, and annual contract volume. | GMP, ISO 9001, food-safety, Halal, and Kosher status should be verified against current site-specific certificates. | Patent ownership and freedom-to-operate position require a jurisdiction-by-jurisdiction search; no unsupported patent number is listed here. | Commercial batch size, minimum order quantity, and release frequency are customer-specific and not publicly disclosed. | Broad formulation suitability; established salt form and relatively straightforward handling. | Medium Technical profile is clear; company-level records require direct verification. |
| 2 | Manufacturer Profile B | Glucosamine salt of 5-methyltetrahydrofolate; commonly positioned for premium supplement formulations | Not publicly disclosed Available capacity depends on campaign scheduling and regional demand. | GMP and ISO-based quality systems may apply, but certificate scope, issuing body, and expiry date must be checked before qualification. | Salt-specific composition, process, and use patents must be reviewed separately from general folate patents. | Representative certificate of analysis should include assay, related substances, residual solvents, water, microbiology, and heavy metals. | Good differentiation for premium products; formulation and stability testing remain necessary. | Medium Product-form information is more reliable than capacity or patent data. |
| 3 | Manufacturer Profile C | Stabilized 5-MTHF intermediate or finished ingredient; final salt and specification depend on the supply agreement | Not publicly disclosed Manufacturing scale should be confirmed through an audit, questionnaire, or supply qualification package. | Site GMP compliance, ISO 9001, HACCP, and allergen-control documentation should be requested for the intended application. | Public patent information may cover synthesis, stabilization, purification, or formulation rather than the ingredient itself. | Batch-release data should be assessed for identity, potency, degradation products, particle size, and storage stability. | Potentially flexible for customized specifications and private-label requirements. | To be verified Public disclosures are insufficient for a definitive ranking. |
| 4 | Manufacturer Profile D | High-purity 5-MTHF ingredient for supplements, medical nutrition, or specialized food applications | Not publicly disclosed Actual output should be evaluated using validated production capacity rather than marketing claims. | Application-specific GMP, ISO 22000 or FSSC 22000, Halal, Kosher, and regulatory dossiers may be available on request. | Patent status should be checked for active claims in the target sales markets; publication alone does not establish enforceability. | Request at least three recent batch certificates to evaluate lot-to-lot consistency and specification compliance. | Strong fit where documentation, traceability, and regulatory support are more important than lowest price. | Medium Quality dimensions are assessable only after document review. |
| 5 | Manufacturer Profile E | 5-MTHF premix, customized blend, or standard folate ingredient supplied for downstream formulation | Not publicly disclosed Premix and blending capacity should be separated from active-ingredient synthesis capacity. | Food-grade GMP, HACCP, ISO 9001, and customer-specific compliance documents should be confirmed for each production site. | Formulation and premix patents may differ from patents covering the 5-MTHF raw material or manufacturing route. | Batch data should include blend uniformity, assay distribution, moisture, microbiological limits, packaging, and retest period. | Useful for turnkey formulation support and smaller or mixed-component production programs. | To be verified Suitability depends heavily on the final product specification. |